"First-In-Man" Clinical trial: HOCM (Hypertrophic Cardiomyopathy) on Apr. 2021


Tau-PNU Medical Inc.


 

We are pleased to announce that our first HOCM (Hypertrophic Obstructive Cardiomyopathy) patient was treated with Tau PNU Medical's TIRA device (Cooled RF Ablation Catheter) at Pusan National University Medical Center on 21st April 2021. This monumental milestone for Tau-PNU Medical is a product of 30 months of intensive R&D and pre-clinical trial efforts from all of our team members of Tau-PNU Medical. This set of early feasibility trials will be performed across accredited medical centers in South Korea.

 



link http://www.tau-pnu.com/newsroom_view.php?no=28&schYear=&schTxt=

LIST

© Tau-Medical Inc. All Rights Reserved.